High-Impact Form 4 Intelligence
Real-time SEC insider trading data with advanced filtering. Free beta.
Total Buys (Filtered)
$0
$0
Total Sells (Filtered)
$1.1M
$1,107,140
| Ticker | Company | Reporting Owner | Date | Value (USD) | Type | Form 4 |
|---|---|---|---|---|---|---|
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
Other
|
2026-03-16 | $47,020 | M | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2026-03-16 | $181,520 | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
Other
|
2026-02-13 | $47,020 | M | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2026-02-13 | $204,180 | S | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
Other
|
2026-01-15 | $47,020 | M | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2026-01-15 | $181,980 | S | Form 4 |
|
MIRM
M
Mirum Pharmaceuticals, Inc.
Ramasastry Saira
• Director
Equity Compensation
2025-12-22
$117,550x2
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
Equity Compensation
|
2025-12-22 | $117,550x2 | M | Form 4 |
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 Sell
|
2025-12-22 | $400,000 | S | Form 4 |
|
MIRM
M
Mirum Pharmaceuticals, Inc.
Ramasastry Saira
• Director
Equity Compensation
2025-12-18
$47,020x2
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
Equity Compensation
|
2025-12-18 | $47,020x2 | M | Form 4 |
|
MIRM
S
Mirum Pharmaceuticals, Inc.
Ramasastry Saira
• Director
10b5-1 SellΔOwn -50.0%
2025-12-18
$139,460x2
|
||||||
| MIRM |
Mirum Pharmaceuticals, Inc.
|
Director
10b5-1 SellΔOwn -50.0%
|
2025-12-18 | $139,460x2 | S | Form 4 |